Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Under the Leadership of Raul Rosenthal, MD and Samuel Szomstein, MD, the Section of Minimally Invasive Surgery (SMIS) and The Bariatric and Metabolic Institute (BMI) at Cleveland Clinic Florida has over 17 full time staff members exclusively dedicated to the care and well being of surgical and morbidly obese patients.
Our staff is multilingual and diverse in ethnicity. Languages spoken fluently are English, Spanish and German. The surgeons operate exclusively at Cleveland Clinic Florida.
This multidisciplinary approach as well as their experience and outcomes are the reason why The Section of Minimally Invasive Surgery and The Bariatric and Metabolic Institute have been named Center of Excellence by the Surgical Review Corporation and the American Society for Metabolic and Bariatric Surgeons, The American College of Surgeons and The Fellowship Council. Close to 1000 General Surgery and Bariatric procedures are performed on a yearly basis by our team. Over 4,000 Bariatric Surgeries have been performed to date at the BMI making it the largest bariatric program in the state of Florida.
Medical research and Education are also cornerstones of the SMIS and BMI.
Over 400 publications including scientific papers, posters, abstracts, book chapters, educational videos and textbooks have been published by the SMIS and BMI.
Under the guidance of Dr. Rosenthal and Dr. Szomstein the Section of Minimally Invasive Surgery and the Bariatric and Metabolic Institute have one of the largest training programs in the USA, mentoring four clinical and four research fellows on a yearly basis. Over the last 10 years, more than 50 fellows trained at our institution.
Fellows that come to Cleveland Clinic Florida from around the globe are involved in both national and international research in the field of obesity, minimally invasive and endoscopic surgical techniques. Both, Dr. Rosenthal and Dr. Szomstein are invited speakers to national and international conferences and have conducted over 11 FDA trials.
Abdominal wall hernia, bariatric surgery, flexible endoscopy, metabolic surgery, minimally invasive surgery
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/5/2016, Dr. Szomstein has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.